GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
Clinical trial NCT06789081 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06789081
- Sponsor
- AHS Cancer Control Alberta
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2028-03-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.